News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amarin Corporation PLC (AMRN) Announces U.S. Patent 8,298,554 Issuance for Vascepa™


10/30/2012 6:50:34 AM

BEDMINSTER, N.J. and DUBLIN, Ireland, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the U.S. Patent and Trademark Office (USPTO) has issued a patent covering the pharmaceutical composition of Amarin's VascepaTM (icosapent ethyl) capsules based on U.S. Patent Application Serial No. 12/769,885. On July 2, 2012, Amarin announced the issuance of a Notice of Allowance for claims under this application. The newly issued patent, U.S. Patent No. 8,298,554, is titled "Highly Stable EPA in a Capsule."

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES